IRVINE, Calif., March 26 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced that it is scheduled to make an investor presentation at the B. Riley & Co. 9th Annual Las Vegas Investor Conference at 8:00 a.m. PT (11:00 a.m. ET) on Friday, April 4, 2008. The conference is being held at the Palms Casino Resort April 2-4, 2008.
A live webcast of the Company's presentation at the conference will be available via a link provided at http://www.endocare.com/investors/webcasts.php. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days. Web participants are encouraged to go to the Company's website (http://www.endocare.com/investors/webcasts.php).
Endocare, Inc. -- http://www.endocare.com -- is an innovative medical
device company focused on the development of minimally invasive
technologies for tissue and tumor ablation. Endocare has initially
concentrated on developing cryoablation (freezing) technologies for the
treatment of prostate cancer and believes that its proprietary technologies
have broad applications across a number of markets, including the ablation
of tumors in the kidney, lung and liver and palliative intervention
(treatment of pain associated with metastases).
Investor Contact: Media Contact:
Matt Clawson Len Hall
Allen & Caron, Inc. Allen & Caron, Inc.
(949) 474-4300 (949) 474-4300
For Additional Information:
Craig T. Davenport, CEO
Michael R. Rodriguez, CFO
|SOURCE Endocare, Inc.|
Copyright©2008 PR Newswire.
All rights reserved